12/23/2025
đ¨BREAKING! HBRF announces positive topline results in stem cell therapy for Parkinson's Disease in a Phase II double-blind, placebo-controlled study of 60 patients. Bottom line: considering all measures, the overwhelming conclusion is that "improvements in motor function are possible through treatment with this cellular therapeutic, and that consistent, repeated treatment may be the most promising path forward for sustained enhancement in motor function for individuals living with Parkinsonâs Disease.â
Did you know? Parkinsonâs is a condition currently considered "incurable" that affects approximately one million in the U.S., with a projected global patient population of 25 million by 2050. What's it all mean? It means these topline results signal a potential game-changer for millions of people.
Read the full release: https://www.businesswire.com/news/home/20251222391584/en/